Ensysce Biosciences, Inc.
Index- P/E0.90 EPS (ttm)0.45 Insider Own33.90% Shs Outstand6.22M Perf Week-0.69%
Market Cap9.90M Forward P/E- EPS next Y- Insider Trans1.18% Shs Float- Perf Month-12.19%
Income2.90M PEG- EPS next Q- Inst Own14.50% Short Float- Perf Quarter-28.78%
Sales- P/S- EPS this Y978.50% Inst Trans- Short Ratio0.57 Perf Half Y-59.30%
Book/sh0.30 P/B1.34 EPS next Y- ROA22.50% Target Price- Perf Year-89.35%
Cash/sh0.00 P/C- EPS next 5Y- ROE107.10% 52W Range0.39 - 7.00 Perf YTD-91.43%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-94.93% Beta-0.11
Dividend %- Quick Ratio0.70 Sales past 5Y- Gross Margin- 52W Low-9.74% ATR0.05
Employees- Current Ratio0.70 Sales Q/Q-70.90% Oper. Margin- RSI (14)34.68 Volatility7.48% 13.47%
OptionableNo Debt/Eq0.26 EPS Q/Q-197.80% Profit Margin- Rel Volume2.29 Prev Close0.40
ShortableYes LT Debt/Eq0.26 Earnings- Payout0.00% Avg Volume1.27M Price0.35
Recom- SMA20-20.30% SMA50-31.79% SMA200-74.08% Volume610,228 Change-11.85%
Sep-06-22 04:15PM  
Sep-01-22 11:14AM  
Aug-31-22 12:54PM  
Aug-24-22 08:05AM  
Aug-23-22 08:05AM  
Aug-17-22 09:20AM  
Aug-11-22 04:10PM  
Aug-09-22 04:20PM  
Jul-27-22 08:05AM  
Jul-13-22 04:05PM  
Jul-01-22 08:30AM  
Jun-27-22 09:15AM  
Jun-21-22 08:00AM  
May-23-22 04:10PM  
May-17-22 08:35AM  
May-12-22 04:10PM  
May-05-22 05:15PM  
Apr-20-22 04:05PM  
Apr-18-22 04:05PM  
Apr-06-22 09:15AM  
Mar-31-22 04:05PM  
Mar-24-22 05:10PM  
Mar-01-22 05:05AM  
Feb-23-22 08:31AM  
Feb-08-22 04:01PM  
Jan-31-22 04:01PM  
Jan-27-22 08:30AM  
Jan-19-22 04:19PM  
Jan-10-22 08:00AM  
Jan-05-22 04:05PM  
Jan-04-22 08:00AM  
Jan-03-22 02:44PM  
Dec-24-21 06:31AM  
Dec-15-21 04:05PM  
Dec-09-21 10:29AM  
Nov-30-21 08:00AM  
Nov-15-21 05:32PM  
Nov-08-21 08:00AM  
Oct-26-21 08:00AM  
Sep-27-21 08:00AM  
Sep-08-21 08:00AM  
Aug-31-21 08:00AM  
Aug-19-21 08:00AM  
Aug-16-21 04:45PM  
Aug-05-21 08:00AM  
Jul-26-21 08:00AM  
Jul-21-21 08:00AM  
Jul-08-21 08:00AM  
Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse. The company is based in La Jolla, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kirkpatrick LynnChief Executive OfficerMay 26Buy0.5327,00014,216381,851May 27 02:05 PM
Kirkpatrick LynnChief Executive OfficerMay 25Buy0.4970,00034,083354,851May 27 02:05 PM